Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

RepHorm

Financiado

Cerrado

A device that will dramatically improve the protection of babies during birth. I...

A device that will dramatically improve the protection of babies during birth. It will monitor the child continuously with better acuity resulting in better clinical outcomes at a lower cost. The objective of this Phase 1 application is a feasibility study to assess the commercial viability of RepHorM, and quantify the business opportunity. This project is to develop a real-time in vivo infant monitor that safe guards... ver más

28/02/2015

BlueBridge Technol...

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

BLUEBRIDGE TECHNOLOGIES LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2015-02-28

PHC-12-2014-1: Clinical research for the validatio...

I+D

Cerrada hace 10 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

BlueBridge Technologies

50.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

IscAlert A Breakthrough Biomedical Sensor for the Continuous Real Tim... 3M€ Cerrado

CliniSenz CliniSenz TM A Cost effective Biosensor for Automatic Con... 71K€ Cerrado

FETAL MONITORING Safe and accurate fetal monitoring 71K€ Cerrado

DESARROLLO DE UNA PLATAFORMA TECNOLOGICA DE E... DESARROLLO DE UNA PLATAFORMA TECNOLOGICA DE E SALUD Y DISPOS... 364K€ Cerrado

Pl ataforma para monitorización de constantes... Pl ataforma para monitorización de constantes vitales y anál... 116K€ Cerrado

SISTEMA INTELIGENTE DE IMAGEN BIOMÉDICA PARA... SISTEMA INTELIGENTE DE IMAGEN BIOMÉDICA PARA LA MONITORIZACI... 396K€ Cerrado

Duración del proyecto: 4 meses Fecha Inicio: 2014-09-29
Fecha Fin: 2015-02-28

Líder del proyecto

BLUEBRIDGE TECHNOLOGIES LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The objective of this Phase 1 application is a feasibility study to assess the commercial viability of RepHorM, and quantify the business opportunity. This project is to develop a real-time in vivo infant monitor that safe guards the baby during birth. This achieved with a fiber optic based biomarker sensor. This device will for the first time provide doctors with a real-time, continuous and objective measure of a baby’s health during labour by incorporating this technology into an existing medical device. The learning curve will be small in taking up the new device and the specific biomarker, is very familiar to obstetricians as well as other clinicians, and the threshold levels for intervention are already established. This Innovative solution uses latest technology deployed to an old, long standing problem. The research into the sensor chemistry has been now completed and this activity has moved the technology form TRL 3 to the current TRL 6. The worldwide market for monitoring was €6.2 Billion in 2010 and is predicted to increase by 4.4% compound annual growth rate (CAGR) to reach € 8 Billion in 2016. None of the current methods offer clear advantages over one another. The general trend in medicine is towards individual bedside or in-patient testing of key biomarkers, in particular, there is a trend towards continuous bio-diagnostics. BlueBridge Technologies hope to use Phase 1 to identify obstacles to successful product development and launch, and develop solutions to manage them. The work will then serve to better understand and describe exactly what type of product(s) the market requires and subsequently estimate the development costs, time to Market and provide the inputs needed for a Phase 2 application. Babies and the market need this product as they are currently under served by the current offerings and we passionately want to lead the response to this noble call.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores